Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC41342 Terrecyclic Acid

    环酸A

    A sesquiterpene
  3. GC41341 Quadrone

    夸德尔酮

    A sesquiterpene with anticancer activity
  4. GC41340 Illudin M

    隐陡头菌素M

    A DNA alkylating agent
  5. GC41317 CAY10625 An inhibitor of survivin - Smac/DIABLO interaction
  6. GC41268 (E)-2-Hexadecenal

    trans-2-Hexadecenal

    A long-chain fatty aldehyde
  7. GC41261 Flavokawain B

    黄卡瓦胡椒素B,Flavokavain B

    Induces cancer cell apoptosis
  8. GC41183 α-Carotene

    α-胡萝卜素

    A precursor of vitamin A
  9. GC41114 Necrostatin-5

    2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-D]嘧啶-2-基]硫代]-乙腈

    A RIP1 kinase inhibitor
  10. GC41112 Dihydroxy Melphalan

    二羟基美法兰

    An inactive degradation product of melphalan
  11. GC41102 15-deoxy-δ12,14-Prostaglandin D2

    15deoxyΔ12,14PGD2

    A metabolite of PGD2 and an agonist of DP2
  12. GC41080 Albofungin

    白真菌素

    A xanthone with diverse biological activities
  13. GC40986 Cinnamamide

    肉桂酰胺

    An amide of trans-cinnamic acid
  14. GC40947 2,3-Dimethoxy-5-methyl-p-benzoquinone

    2,3-二甲氧基-5-甲基-1,4-苯醌,CoQ0

    An intermediate in the synthesis of ubiquinones that has anticancer activity
  15. GC40932 S-trityl-L-Cysteine

    NSC 83265; S-Tritylcysteine; 3-Tritylthio-L-alanine

    An inhibitor of Eg5
  16. GC40909 Lonicerin

    忍冬苦苷

    A flavonoid with diverse biological activities
  17. GC40901 Isogarcinol

    Cambogin

    A natural benzophenone that has immunosuppressant actions
  18. GC40878 Chelidonine

    白屈菜碱

    A tertiary hexahydro-benzophenanthridine alkaloid
  19. GC40872 Zinquin ethyl ester

    乙基2-(2-甲基-8-(4-甲基苯基磺酸基N乙酰胺基)喹啉-6-氧基)乙酸酯

    A fluorescent probe for zinc
  20. GC40865 LYG-202 A synthetic flavonoid with anticancer and anti-angiogenic activities
  21. GC40861 Pinosylvin

    赤松素

    A stilbene with diverse biological activities
  22. GC40859 Steffimycin B

    司替霉素B

    An anthracycline bacterial metabolite
  23. GC40791 MS-1020 A cell-permeable inhibitor of JAK3
  24. GC40785 9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester

    αESA ethyl ester, Ethyl αeleostearate

    A polyunsaturated fatty acid ethyl ester
  25. GC40760 Nonanoic Acid methyl ester

    壬酸甲酯

    An esterified form of nonanoic acid
  26. GC40758 Gly-Phe-β-naphthylamide

    (S)-2-(2-氨基乙酰氨基)-N-(萘-2-基)-3-苯基丙酰胺

    A cathepsin C substrate
  27. GC40715 Ascochlorin

    壳二孢氯素,Ilicicolin D

    An isoprenoid antibiotic and antiviral
  28. GC40710 9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester

    9顺,11反,13反-十八碳三烯酸甲酯

    A polyunsaturated fatty acid methyl ester
  29. GC40698 (-)-Perillyl Alcohol

    紫苏醇

    A monoterpene alcohol with diverse biological activities
  30. GC40690 C6 L-threo Ceramide (d18:1/6:0)

    L-threo Cer(d18:1/6:0), L-threo Ceramide (d18:1/6:0), N-hexanoyl-L-threo-Sphingosine

    A bioactive sphingolipid
  31. GC40689 C6 L-erythro Ceramide (d18:1/6:0)

    L-erythro Cer(d18:1/6:0), L-erythro Ceramide (d18:1/6:0), N-hexanoyl-L-erythro-Sphingosine

    A bioactive sphingolipid
  32. GC40688 C6 D-threo Ceramide (d18:1/6:0)

    N-hexanoyl-D-threo-Sphingosine, D-threo Cer(d18:1/6:0), D-threo Ceramide (d18:1/6:0)

    A bioactive sphingolipid
  33. GC40675 2-deoxy-Artemisinin

    脱氧青蒿素

    An inactive metabolite of artemisinin
  34. GC40673 Geranyl Acetate

    乙酸香叶酯

    A monoterpene with diverse biological activities
  35. GC40669 Nerol

    橙花醇

    A monoterpene
  36. GC40664 Colcemid

    秋水仙碱,Demecolcine

    Colcemid是一种细胞骨架抑制剂,可以在哺乳动物细胞或卵母细胞中诱导G2/M期的有丝分裂停滞或囊泡破裂(GVBD)期的减数分裂停滞。
  37. GC40655 NVP-BKM120

    布帕尼西; BKM120; NVP-BKM120

    An inhibitor of class I PI3K isoforms
  38. GC40650 CAY10706 A TrxR inhibitor
  39. GC40614 Anhydroepiophiobolin A

    3-Anhydro-6-epi-ophiobolin A

    A sesterterpenoid fungal metabolite
  40. GC40556 Ac-LETD-AFC

    NAcetylLeuGluThrAsp7amino4Trifluoromethylcoumarin, Caspase8 Substrate (Fluorogenic)

    A caspase-8 fluorogenic substrate
  41. GC40483 Patulin

    棒曲霉素; Terinin

    A mycotoxin

  42. GC40334 Myristoleic Acid methyl ester

    肉豆蔻脑酸甲酯

    Methyl ester of the cytotoxin myristoleic acid
  43. GC19541 (rac)-Antineoplaston A10

    3-苯基乙酰氨基-2,6-哌啶二酮

    (rac)-Antineoplaston A10 是 Antineoplaston A10 的外消旋体。 Antineoplaston A10 是一种潜在的 Ras 抑制剂,可用于治疗神经胶质瘤、淋巴瘤、星形细胞瘤和乳腺癌。
  44. GC19537 β-Elemene

    β-榄香烯; (-)-β-Elemene; Levo-β-elemene

    An analytical standard for the detection of β-elemene
  45. GC19533 Infliximab

    英夫利昔单抗,Avakine; CT-P13

    英夫利昔单抗是一种嵌合单克隆 IgG1 抗体,可特异性结合 TNF-α。

  46. GC19531 Pembrolizumab

    派姆单抗,帕博利珠单抗,Lambrolizumab; MK-3475

    Pembrolizumab 是一种抗程序性死亡 1 单克隆抗体,已在晚期实体癌患者中证明具有临床显着的抗肿瘤活性和可接受的安全性,并已被美国 FDA 批准用于治疗晚期黑色素瘤、NSCLC、头颅和脑肿瘤。
  47. GC34929 PD-1-IN-17 TFA An inhibitor of PD-1 signaling
  48. GC34928 PD-1-IN-17 An inhibitor of PD-1 signaling
  49. GC34862 WYC-209

    4,5-二(羟甲基)-2-苯基-1H-咪唑

    WYC-209是一种合成类视黄醇,能抑制恶性小鼠黑色素瘤肿瘤再生细胞(TRC)的增殖,IC50值为0.19μM。WYC-209主要细胞靶点是维甲酸受体(RARs)。
  50. GC34831 Tauroursodeoxycholate dihydrate

    牛磺熊去氧胆酸二水合物; Tauroursodeoxycholic acid dihydrate; TUDCA dihydrate; UR 906 dihydrate

    Tauroursodeoxycholatedihydrate(TUDCAdihydrate;UR906dihydrate;Taurolitedihydrate)是一种内质网应激抑制剂。Tauroursodeoxycholate显著降低凋亡分子如caspase-3和caspase-12表达。Tauroursodeoxycholate也抑制ERK。
  51. GC34642 KI696 isomer KI696isomer是KI696的低活性异构体。KI696是一种高亲和力探针,可破坏Keap1/NRF2相互作用。

Items 1401 to 1450 of 2517 total

per page

Set Descending Direction